azabicyclo compounds

Preferred Label : azabicyclo compounds;

MeSH definition : Bicyclic bridged compounds that contain a nitrogen which has three bonds. The nomenclature indicates the number of atoms in each path around the rings, such as [2.2.2] for three equal length paths. Some members are TROPANES and BETA LACTAMS.;

MeSH hyponym : Azabicyclo(4.3.0)Nonanes; Azabicyclo(2.2.2)Octanes; Azabicyclo(1.1.0)Butanes; Azabicyclo(5.2.2)Undecanes; Azabicyclo(3.3.1)Nonanes;

Is substance : O;

Details

Origin ID

D053961;

UMLS CUI

C1955840;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Azabicyclo compound (substance) [SNOMED CT concept]
Record concept(s)
- Azabicyclo(1.1.0)Butanes [MeSH concept]
- Azabicyclo(2.2.2)Octanes [MeSH concept]
- Azabicyclo(3.3.1)Nonanes [MeSH concept]
- Azabicyclo(4.3.0)Nonanes [MeSH concept]
- Azabicyclo(5.2.2)Undecanes [MeSH concept]
- azabicyclo compounds [MeSH concept]
Related MeSH Supplementary Concept(s)
- (6-((2',4'-dimethyl-(4,5'-bithiazol)-2-yl)amino)pyridin-3-yl)(7-(5-(trifluoromethyl)pyrimidin-2-yl)-3-oxa-7,9-diazabicyclo(3.3.1)nonan-9-yl)methanone [MeSH Supplementary Concept]
- 1,2-diazabicyclo(3.3.1)nonane [MeSH Supplementary Concept]
- 1,3,3,5-tetramethyl-6-azabicyclo(3.2.1)octane [MeSH Supplementary Concept]
- 1,4,7,10,13,16,21,24-octaazabicyclo(8.8.8)hexacosane [MeSH Supplementary Concept]
- 1,4-diazabicyclo(3.2.2)nonan-4-yl(5-(3-(trifluoromethyl)phenyl)furan-2-yl)methanone [MeSH Supplementary Concept]
- 1,9-dioxa-4-azaspiro(5.5)undecane [MeSH Supplementary Concept]
- 1-((6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile [MeSH Supplementary Concept]
- 1-(10-((E)-3-phenyl-allyl)-3,10-diaza-bicyclo(4.3.1)dec-3-yl)propan-1-one [MeSH Supplementary Concept]
- 1-(2-(2,5-diazabicyclo(2.2.1)hept-2-yl)pyridin-4-yl)-N-pyrazin-2-yl-1H-indazol-3-amine [MeSH Supplementary Concept]
- 1-(3,4-dichlorophenyl)-6-(methoxymethyl)-4-azabicyclo(4.1.0)heptane [MeSH Supplementary Concept]
- 1-(6-chloro-3-pyridylmethyl)-7-methyl-8-nitro-1,2,3,5,6,7-hexahydroimidazo(1,2-a)pyridin-5-ol [MeSH Supplementary Concept]
- 1-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1,3-dihydro-2H-indol-2-one [MeSH Supplementary Concept]
- 1-(naphthalen-2-yl)-3-azabicyclo(3.1.0)hexane [MeSH Supplementary Concept]
- 1-aza-7-benzyloxycarbonylamino-8-oxo-4-thiabicyclo(3.3.0)octane-2-carbonitrile [MeSH Supplementary Concept]
- 1-methyl-1H-imidazole-4-carboxylic acid (3-chloro-4-fluoro-benzyl)-(3-methyl-3-aza-bicyclo(3.1.0) hex-6-ylmethyl)amide [MeSH Supplementary Concept]
- 1-methyl-8-amino-3,13,16-trithia-6,10,19-triazabicyclo(6.6.6)eicosane [MeSH Supplementary Concept]
- 13-ethyl-4-oxa-13-azabicyclo(10.2.0)tetradec-1-en-14-one [MeSH Supplementary Concept]
- 18-(5-methyl-2,5-diazabicyclo(2.2.1)heptan-2-yl)-18-oxooctadec-9-en-7-yl phenylacetate [MeSH Supplementary Concept]
- 2,3-dimethoxy-5-(30-(18F)fluoropropyl)- N-(1-azabicyclo(2.2.2)oct-3-yl)benzamide [MeSH Supplementary Concept]
- 2,4,6,8-(3)-tetranitrophenyl-3,7-diazabicyclo(3.3.1)nonan-9-one [MeSH Supplementary Concept]
- 2-(1,4-diazabicyclo(3.2.2)nonan-4-yl)-5-phenyl-1,3,4-oxadiazole [MeSH Supplementary Concept]
- 2-(6-(((6-fluoroquinolin-2-yl)methyl)amino)bicyclo(3.1.0)hex-3-yl)-N-hydroxypyrimidine-5-carboxamide [MeSH Supplementary Concept]
- 2-(6-fluoro-2,3'-bipyridin-5'-yl)-7-methyl-7-azabicyclo(2.2.1)heptane [MeSH Supplementary Concept]
- 2-(6-methyl-3,6-diazabicyclo(3.2.0)heptan-3-yl)-7-(6-methyl-3,6-diazabicyclo(3.2.0)heptan-3-yl)-9H-fluoren-9-one [MeSH Supplementary Concept]
- 2-chloro-4-(3-hydroxy-3-methyl-8-azabicyclo(3.2.1)oct-8-yl)-3-methylbenzonitrile [MeSH Supplementary Concept]
- 2-chloro-4-(4-hydroxy-3-methoxy-3a,4,5,6-tetrahydro-3H-pyrrolo(1,2-b)pyrazol-2-yl)-3-methylbenzonitrile [MeSH Supplementary Concept]
- 3-(1,4-diazabicyclo(3.2.2)nonan-4-yl)-6-fluorodibenzo(b,d)thiophene 5,5-dioxide [MeSH Supplementary Concept]
- 3-(2,16-dioxo-19-(4-phenylbutyl)-3,19-diazabicyclo(15.2.1)icosa-1(20),6,17-trien-3-yl)propyl dihydrogen phosphate [MeSH Supplementary Concept]
- 3-(3-bromothiophen-2-yl)-8-methyl-8-azabicyclo(3.2.1)oct-2-ene [MeSH Supplementary Concept]
- 3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo(3.2.0)heptane [MeSH Supplementary Concept]
- 3-(6-p-tolylpyridin-3-yloxy)-1-azabicyclo(2.2.2)octane [MeSH Supplementary Concept]
- 3-azabicyclo(3.2.1)octan-1-yl-leucyl-tryptophyl-4-chlorophenylalanine [MeSH Supplementary Concept]
- 3-isopinocampheylamine [MeSH Supplementary Concept]
- 4-(3-fluoroazetidin-1-yl)-7-methyl-5-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)imidazo(5,1-f)(1,2,4)triazine [MeSH Supplementary Concept]
- 4-(4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1H,4H,5H,6H-pyrrolo(3,4-c)pyrazol-5-yl)benzoic acid [MeSH Supplementary Concept]
- 4-(5-(1-methyl-1H-pyrrol-2-yl)-1,3,4-oxadiazol-2-yl)-1,4-diazabicyclo(3.2.2)nonane [MeSH Supplementary Concept]
- 4-(5-methyloxazolo(4,5-b)pyridin-2-yl)-1,4-diazabicyclo(3.2.2)nonane [MeSH Supplementary Concept]
- 4-iodophenyl 1,4-diazaicyclo(3.2.2)nonane-4-carboxylate [MeSH Supplementary Concept]
- 5'-(2-fluorophenyl)-spiro(1-azabicyclo(2.2.2)octane-3,2'(3'H)-furo(2,3-b)pyridine) [MeSH Supplementary Concept]
- 5-(3,6-diazabicyclo(3.2.0)heptan-6-yl)nicotinonitrile [MeSH Supplementary Concept]
- 5-(3-hydroxyphenyl)-2-phenethyl-2-azabicyclo(3.3.1)nonan-4-ol [MeSH Supplementary Concept]
- 5-hydroxy diazabicyclo(4.3.1)decane-2-one [MeSH Supplementary Concept]
- 6-allyl-2-benzylidene-8-(4-methoxybenzyl)-6,8-diazabicyclo(3.2.2)nonane [MeSH Supplementary Concept]
- 6-allyl-2-benzyloxy-8-(4-methoxybenzyl)-6,8-diazabicyclo(3.2.2)nonane [MeSH Supplementary Concept]
- 6-azabicyclo(3.2.1)octane [MeSH Supplementary Concept]
- 6-benzyl-2-methoxy-8-(4-methoxybenzyl)-6,8-diazabicyclo(3.2.2)nonane [MeSH Supplementary Concept]
- 8-(bis(2-chlorophenyl)methyl)-3-(2-pyrimidinyl)-8-azabicyclo(3.2.1)octan-3-ol [MeSH Supplementary Concept]
- 8-(bis(2-methylphenyl)methyl)-3-phenyl-8-azabicyclo(3.2.1)octan-3-ol [MeSH Supplementary Concept]
- 8-oxo-7-(2-oxo-2H-chromene-3-carboxamido)-3-((4-(2-oxo-2H-chromene-3-carboxamido)-phenylthio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid [MeSH Supplementary Concept]
- 9-(8-azabicyclo(3.2.1)oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide [MeSH Supplementary Concept]
- 9-azabicyclo(3.3.1)nonane-N-oxyl [MeSH Supplementary Concept]
- AC-262536 [MeSH Supplementary Concept]
- BRD7929 [MeSH Supplementary Concept]
- CP-866,087 [MeSH Supplementary Concept]
- CWP232228 [MeSH Supplementary Concept]
- DBT-10 [MeSH Supplementary Concept]
- EAA-090 [MeSH Supplementary Concept]
- GSK 163929 [MeSH Supplementary Concept]
- GSK598809 [MeSH Supplementary Concept]
- ML218 compound [MeSH Supplementary Concept]
- N'-(3,5-bis(trifluoromethyl)phenyl)-2-(hexahydropyrrolo(1,2-a)pyrazin-2(1H)-yl)-2-(3-pyridinyl)ethanohydrazide [MeSH Supplementary Concept]
- N-(1-(3-chloro-4-hydroxyphenyl)-3-(1,1-dimethylethyl)-1H-pyrazol-5-yl)-N'-((2-((3-(2-((2-hydroxyethyl)thio)phenyl)-1,2,4-triazolo(4,3-a)pyridin-6-yl)thio)phenyl)methyl)-urea [MeSH Supplementary Concept]
- N-(1-azabicyclo(2.2.2)oct-3-yl)(5-(2-pyridyl)thiopene-2-carboxamide) [MeSH Supplementary Concept]
- N-(1-azabicyclo(2.2.2)oct-3-yl)(5-(2-pyridyl)thiophene-2-carboxamide) [MeSH Supplementary Concept]
- N-(1-azabicyclo(3.2.1)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide [MeSH Supplementary Concept]
- N-(2-methyl-5-(9-oxa-3,7-diazabicyclo(3.3.1)non-3-ylcarbonyl)phenyl)-2-tricyclo(3.3.1.13,7)dec-1-ylacetamide [MeSH Supplementary Concept]
- N2-methyl-N-((2-(4-(trifluoromethyl)phenyl)octahydrocyclopenta(c)pyrrol-4-yl)leucinamide [MeSH Supplementary Concept]
- NBI 77860 [MeSH Supplementary Concept]
- NS 10743 [MeSH Supplementary Concept]
- O,O'-di-(3-(2-carboxy-8-oxo-7-(2-thiophen-2-yl-acetylamino)-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)allyl)-2',7'-dichlorofluorescein [MeSH Supplementary Concept]
- PF 232798 [MeSH Supplementary Concept]
- PF 4575180 [MeSH Supplementary Concept]
- PF-04634817 [MeSH Supplementary Concept]
- PF-06687252 [MeSH Supplementary Concept]
- PF-06835919 [MeSH Supplementary Concept]
- PRX-14040 [MeSH Supplementary Concept]
- S 38093 [MeSH Supplementary Concept]
- S-4-(4-ethyl-7-isopropyl-2,5,8,12-tetraoxo-9-oxa-3,6,13,18-tetraazabicyclo(13,2,1)octadec-1-en-10-yl)but-3-enyl octanethioate [MeSH Supplementary Concept]
- SB2602 [MeSH Supplementary Concept]
- SCH 655842 [MeSH Supplementary Concept]
- SM16 compound [MeSH Supplementary Concept]
- SV119 [MeSH Supplementary Concept]
- SW IV-134 [MeSH Supplementary Concept]
- SW120 compound [MeSH Supplementary Concept]
- SW43-DOX compound [MeSH Supplementary Concept]
- TAK 593 [MeSH Supplementary Concept]
- TC-8581 [MeSH Supplementary Concept]
- TC-8831 [MeSH Supplementary Concept]
- TD-5108 [MeSH Supplementary Concept]
- VU0455691 [MeSH Supplementary Concept]
- WCK 4234 [MeSH Supplementary Concept]
- XL 888 [MeSH Supplementary Concept]
- XL647 [MeSH Supplementary Concept]
- ZYKR1 [MeSH Supplementary Concept]
- acebilustat [MeSH Supplementary Concept]
- alpha-hydroxy 6-azabicyclo(3.2.1)octanone [MeSH Supplementary Concept]
- aplaminal [MeSH Supplementary Concept]
- avibactam [MeSH Supplementary Concept]
- avibactam, ceftazidime drug combination [MeSH Supplementary Concept]
- azinomycin A [MeSH Supplementary Concept]
- banyaside [MeSH Supplementary Concept]
- cefepime, enmetazobactam drug combination [MeSH Supplementary Concept]
- cefepime-zidebactam [MeSH Supplementary Concept]
- durlobactam [MeSH Supplementary Concept]
- enmetazobactam [MeSH Supplementary Concept]
- eucophylline [MeSH Supplementary Concept]
- gadopiclenol [MeSH Supplementary Concept]
- imipenem, cilastatin and relebactam [MeSH Supplementary Concept]
- incarvine C [MeSH Supplementary Concept]
- isopropyl 8-(5-methyl-6-(2-methylpyridin-3-yloxy)pyrimidin-4-yloxy)-6-oxa-3-azabicyclo(3.2.1)octane-3-carboxylate [MeSH Supplementary Concept]
- isopropyl 9-((5-methyl-6-((2-methylpyridin-3-yl)oxy)pyrimidin-4-yl)oxy)-3-oxa-7-azabicyclo(3.3.1)nonane-7-carboxylate [MeSH Supplementary Concept]
- lycojaponicumin A [MeSH Supplementary Concept]
- lycojaponicumin B [MeSH Supplementary Concept]
- lycojaponicumin C [MeSH Supplementary Concept]
- lycopladine H [MeSH Supplementary Concept]
- methyl 8-(2-(3,4-dichlorophenyl)acetyl)-2-(pyrrolidin-1-yl)-6,8-diazabicyclo(3.2.2)nonane-6-carboxylate [MeSH Supplementary Concept]
- nacubactam [MeSH Supplementary Concept]
- paichongding [MeSH Supplementary Concept]
- petasitenine [MeSH Supplementary Concept]
- pqr620 [MeSH Supplementary Concept]
- pyclen [MeSH Supplementary Concept]
- relebactam [MeSH Supplementary Concept]
- spumigin HKVV [MeSH Supplementary Concept]
- sulbactam-durlobactam [MeSH Supplementary Concept]
- suomilide [MeSH Supplementary Concept]
- tert-butyl (2-(7-(2-(4-cyano-2-fluorophenoxy)ethyl)-9-oxa-3,7-diazabicyclo(3.3.1)non3-yl)ethyl)carbamate [MeSH Supplementary Concept]
- triazabicyclodecene [MeSH Supplementary Concept]
- zidebactam [MeSH Supplementary Concept]
- zopiclone [MeSH Supplementary Concept]
- zwiebelane A [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Azabicyclo compound (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients